Hepatitis C-Positive Heart Transplantation: Good Outcomes and Shortened Wait Times

摘要

The opioid epidemic has resulted in a significant increase in hepatitis C virus (HCV)-exposed donors. A recently published clinical trial of HCV-positive to HCV-negative transplantation of chest organs demonstrated excellent 6-month survival and HCV cure when direct-acting antivirals (DA As) were started immediately after transplant